Predictive Models Could Help Diagnose Early-stage Parkinson’s, Study Finds
Predictive models can help diagnose Parkinson’s disease in early stages, and could be used to distinguish Parkinson’s from conditions…
Articles by Marisa Wexler, MS
Self-care Skills Program Improves Daily Life for Patients and Caregivers, Study Finds
A program that teaches Parkinson’s patients and their caregivers techniques to manage day-to-day activities over the course of this disease can help…
Researchers Think COVID-19 May Increase Parkinson’s Risk, Pointing to Need for Detailed Record-keeping
Although there isn’t currently sufficient evidence to draw definitive conclusions, it is possible that people who survive COVID-19 may…
McIntyre Powder Used in Mining Linked to Parkinson’s Disease in Study
Inhaled McIntyre powder, which was used in the mining industry during the mid-20th century, is associated with an increased risk…
Study Finds Yoga and Occupational Therapy Program Well-received by Parkinson’s Patients
A fall prevention program that combines yoga and occupational therapy was well-received by people living with Parkinson’s disease,…
Depression Linked with Malnutrition in Elderly with Parkinson’s, Study Finds
Depression and anxiety can be prevalent among elderly people hospitalized with Parkinson’s disease, and is associated with malnourishment or poor…
Large Platform (MAMS) Trials Necessary for Parkinson’s, Review Argues
A clinical trial that’s multi-arm and multi-stage (MAMS) could quicken development of promising therapies for Parkinson’s disease (PD) by allowing…
Study Suggests Mechanism Behind Levodopa-induced Dyskinesia in Parkinson’s
The protein RasGRP1 is a key culprit for involuntary movements that arise from dopamine replacement therapies used to treat…
Metabolic Syndrome, Cause of Heart Disease and Diabetes, Linked To LRRK2 Mutations
Certain features of metabolic syndrome may be more prevalent in people with Parkinson’s disease-associated mutations in the gene LRRK2, new…
FDA Names Spectramax Light Therapy ‘Breakthrough Device’ for Parkinson’s
The United States Food and Drug Administration (FDA) has granted breakthrough device designation to PhotoPharmics‘s light-based, at-home…